A California biotech steps into the viral vector space with new site build of $75M

SourceEndpoints News
Date Published10/14/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Avid Bioservices
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2023
Domestically, the work will be done:In-house
Capital investment ($):75
City reshored to:Tustin
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredCDMO, cell and gene therapy, viral vector cGMP man
Find Reshoring Articles